Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,622,000 | 4,584,000 | 2,271,000 | 3,010,000 | 7,882,000 |
| Depreciation Amortization | 6,471,000 | 4,406,000 | 2,114,000 | 559,000 | 2,017,000 |
| Income taxes - deferred | -2,325,000 | -498,000 | -257,000 | -181,000 | 122,000 |
| Accounts receivable | -929,000 | -574,000 | -543,000 | -1,025,000 | -74,000 |
| Accounts payable and accrued liabilities | 1,514,000 | 1,903,000 | 466,000 | 1,025,000 | 97,000 |
| Other Working Capital | 969,000 | 1,519,000 | 497,000 | 96,000 | -1,408,000 |
| Other Operating Activity | 7,266,000 | 1,394,000 | 2,356,000 | 331,000 | 4,688,000 |
| Operating Cash Flow | $17,588,000 | $12,734,000 | $6,904,000 | $3,815,000 | $13,324,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -798,000 | -519,000 | -302,000 | -125,000 | -552,000 |
| Net Acquisitions | -39,610,000 | -39,210,000 | -38,330,000 | -12,000 | -1,135,000 |
| Purchase Of Investment | -61,000 | -47,000 | -32,000 | -13,000 | -583,000 |
| Sale Of Investment | 1,525,000 | 1,464,000 | 1,429,000 | 26,000 | 2,699,000 |
| Other Investing Activity | 1,387,000 | 1,382,000 | 1,454,000 | -5,000 | 167,000 |
| Investing Cash Flow | $-37,557,000 | $-36,930,000 | $-35,781,000 | $-129,000 | $596,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | -699,000 |
| Debt Issued | 3,000,000 | 3,000,000 | 3,000,000 | N/A | 31,482,000 |
| Debt Repayment | -5,683,000 | -4,414,000 | -3,763,000 | N/A | -1,536,000 |
| Common Stock Issued | 209,000 | 109,000 | 77,000 | 12,000 | 8,000 |
| Common Stock Repurchased | -978,000 | -682,000 | -662,000 | -643,000 | -629,000 |
| Dividend Paid | -7,716,000 | -5,615,000 | -3,515,000 | -1,763,000 | -6,366,000 |
| Other Financing Activity | -333,000 | -204,000 | -129,000 | -28,000 | -3,552,000 |
| Financing Cash Flow | $-11,501,000 | $-7,806,000 | $-4,992,000 | $-2,422,000 | $18,708,000 |
| Exchange Rate Effect | -5,000 | -32,000 | -38,000 | -46,000 | 7,000 |
| Beginning Cash Position | 39,924,000 | 39,924,000 | 39,924,000 | 39,924,000 | 7,289,000 |
| End Cash Position | 8,449,000 | 7,890,000 | 6,017,000 | 41,142,000 | 39,924,000 |
| Net Cash Flow | $-31,475,000 | $-32,034,000 | $-33,907,000 | $1,218,000 | $32,635,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 17,588,000 | 12,734,000 | 6,904,000 | 3,815,000 | 13,324,000 |
| Capital Expenditure | -798,000 | -519,000 | -302,000 | -125,000 | -552,000 |
| Free Cash Flow | 16,790,000 | 12,215,000 | 6,602,000 | 3,690,000 | 12,772,000 |